Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  US Nuclear Corp.    UCLE


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

US NUCLEAR CORP. : Other Events (form 8-K)

05/14/2020 | 07:37am EST

Item 8.01 Other Events

Delayed Filing of Quarterly Report on Form 10-K and Reliance on Order Regarding 45-Day Extension

US Nuclear Corp. (the "Company,") files this Current Report on Form 8-K ("Report") in reliance on the Securities and Exchange Commission ("SEC") order dated March 25, 2020, Release No. 34-88465. The purpose of this Report is to notify investors and the public at large of its inability to timely file its Quarterly Report on Form 10-Q for the First Quarter of the 2020 Fiscal Year ("Quarterly Report") due to the circumstances related to the novel coronavirus and its related disease known as COVID-19.

The Company is based in California. On March 18, 2020, the Governor of California issued a "Stay at Home" order due to the novel coronavirus, which has subsequently been extended indefinitely by the Governor of California. The Stay at Home order has limited the Company's staff and hampered the Company's ability to conduct necessary work to finalize its financial statements and otherwise finalize the Quarterly Report. As a result, the Company anticipates filing its Quarterly Report on or before June 29, 2020. The Company also provides the following risk factor related to the novel coronavirus below, which was previously provided in the Company's Form 8-K dated March 30, 2020.

Risk Factor

The Novel Coronavirus May Adversely Affect the Company and its Business

The Company is based in Canoga Park, California, and operates in states around the United States. The novel coronavirus known as COVID-19 (the "Coronavirus") has caused the Governor of the State of California to issue a "Stay at Home" order requiring, in short, all nonessential business to close and for individuals to stay in their homes but for certain, necessary activities. This order affects the Company, as well as its clients, suppliers, and employees, and may adversely affect the Company's business or the Company's ability to operate. Further government intervention or regulation may significantly impact the Company's ability to operate. Investors and potential investors should consider the current governmental regulations, as well as the possibility of additional intervention, in owning or purchasing the Company's stock.

© Edgar Online, source Glimpses

All news about US NUCLEAR CORP.
01/21US Nuclear Corp. Discusses Potential of 2021 Projects with The Stock Day Podc..
01/06US NUCLEAR CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
01/06US NUCLEAR : 2019 Convertible Debenture Now Fully Converted, Closed, and Flat
2020US Nuclear Corp. Discusses The Progress of Its MIFTEC Contract and Overhuff T..
2020US Nuclear Corp. Announces Third Quarter 2020 Results
2020US NUCLEAR : Management's Discussion and Analysis of Financial Condition and Res..
2020US NUCLEAR : and Grapheton Brain Implants to Help Immobilized Patients
2020US Nuclear and Grapheton Brain Implants to Help Immobilized Patients
2020US NUCLEAR : Secures Its Position at Bioelectronics Startup Grapheton
2020US Nuclear Secures Its Position at Bioelectronics Startup Grapheton
More news
Financials (USD)
Sales 2019 3,54 M - -
Net income 2019 -3,16 M - -
Net cash 2019 0,10 M - -
P/E ratio 2019 -4,28x
Yield 2019 -
Capitalization 10,6 M 10,6 M -
EV / Sales 2018 2,02x
EV / Sales 2019 3,85x
Nbr of Employees 20
Free-Float 48,4%
Duration : Period :
US Nuclear Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Robert I. Goldstein Chairman, President & Chief Executive Officer
Richard Landry COO & Director-Investor Relations
Rachel Boulds Chief Financial Officer & Secretary
Michael G. Hastings Director
Dell Williamson Director
Sector and Competitors